Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07402057Not ApplicableRecruiting

Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations

Role: collaborator

NCT06963203Recruiting

Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

Role: collaborator

NCT05569980Enrolling By Invitation

The Nordic Rectal Prolapse Study

Role: collaborator

NCT05729230Completed

PAtient-PHYsician Relationship Assessment

Role: collaborator

NCT05095064Unknown

Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan

Role: collaborator

NCT04473027Terminated

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs

Role: collaborator

All 6 trials loaded